Effect of Different Positive End Expiratory Pressures on Regional Cerebral Oxygen Saturation

July 18, 2023 updated by: Halide Hande Şahinkaya, Bozyaka Training and Research Hospital

Evaluation of the Effect of Different PEEP Levels on Regional Cerebral Oxygen Saturation in Patients Undergoing Elective Craniotomy for Excision of Brain Tumors ; Randomized Controlled Clinical Trial

The goal of this prospective single-blind randomized clinical trial is to compare the effect of two different positive end expiratory pressure (PEEP) levels on regional cerebral oxygen saturation in patients scheduled for craniotomy due to supratentorial masses.

The main question it aims to answer is that how high PEEP level effects the regional cerebral oxygen saturation in patients with high intracranial pressure due to mass effect. Patients will be divided into two groups as Group low PEEP (5 cmH2O) and Group high PEEP (10 cmH2O). Researchers will compare the changes of regional cerebral oxygen saturations between two groups by near infra-red spectroscopy.

Study Overview

Detailed Description

In this prospective single-blind study, American Society of Anesthesiologists physical status classification system (ASA) I and II patients aged older than 18 years undergoing craniotomy will be enrolled for the study. Patients will be divided into two groups with computer-based randomization technique. Written and verbal approval will be taken from all patients. Premedication will not be used. Patients will be monitorized by standard non-invasive monitorization (electrocardiography, non-invasive blood pressure measurement, peripheral oxygen saturation) in the operating room. Cerebral/somatic oximeter, near infra-red spectroscopy (NIRS) sensor will be placed on the frontotemporal area and regional cerebral oxygen saturation will be monitorized continuously. Remifentanil infusion with a dose of 0.25 mcg/kg/min will be started two minutes before the induction. After preoxygenation with 6 L/min oxygen for 5 minutes, general anesthesia induction for patients in both groups will be held with intravenous 2 mg/kg propofol. Rocuronium bromide (0.6 mg/kg) will be used for muscle relaxation. Endotracheal intubation will be performed. Controlled mechanical ventilation will be used during the surgery. Invasive arterial blood pressure monitorization will be done and a central venous catheter will be placed in both groups.

In group low PEEP, the patients' settings of mechanical ventilation will be as tidal volume 6-8 mL/kg, inspired oxygen fraction (FiO2) 0.4, PEEP 5 cmH2O. Frequency will be set according to the end tidal carbon dioxide pressure (ETCO2) where it will be 30-32 mmHg.

In group high PEEP, the patients' settings of mechanical ventilation will be as tidal volume 6-8 mL/kg, inspired oxygen fraction (FiO2) 0.4, PEEP 10 cmH2O. Frequency will be set according to the end tidal carbon dioxide pressure (ETCO2) where it will be 30-32 mmHg.

Remifentanil with a dose of 0.05-2 mcg kg/min and propofol with a dose of 50-200 mcg/kg/min will be infused for general anesthesia maintenance in both groups. Dose of remifentanil infusion will be changed according to the blood pressure. If the mean arterial blood pressure and/or heart rate will decrease to 20% of the baseline mean arterial blood pressure and heart rate, the infusion dose will be lowered. If this decrease in heart rate will be over 25%, intravenous 0.5 mg atropin will be administered. If the mean arterial blood pressure will be under 55 mmHg, intravenous 5 mg ephedrine will be administered. If the mean arterial blood pressure will continue to decrease, PEEP will be lowered. If the peripheral oxygen saturation will be under 92%, the inspired oxygen fraction or PEEP will be increased. In these conditions, the patient will be out of study.

1 gr paracetamol will be given intravenously for pain relief. Sugammadex will be used with a dose of 4 mg/kg for extubation.

Regional cerebral oxygen saturation measures will be recorded nine (9) times during the study; pre-induction (period 1), post-induction (period 2), skull pinning (period 3), before dura opening (period 4), after dura opening (period 5), surgical resection of the mass (period 6), dura closure (period 7), end of the surgery (period 8) and end of anesthesia (period 9).

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bozyaka
      • İzmir, Bozyaka, Turkey
        • Recruiting
        • University of Health Sciences İzmir Bozyaka Education and Research Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Older than 18 years
  • American Society of Anesthesiologists physical status classification system (ASA) I and II
  • Patients scheduled for elective craniotomy
  • Patients with supratentorial mass

Exclusion Criteria:

  • Hemoglobin concentration lower than 9 mg/dL
  • Uncontrolled hypertension
  • Congestive heart failure
  • Severe chronic obstructive lung disease
  • Cerebrovascular disease
  • Pulmonary edema
  • History of carotis surgery or stenosis of carotid artery
  • Unstable hemodynamics
  • Pregnancy
  • Skin reaction to the NIRS sensor
  • Patient's refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group low PEEP
Positive end-expiratory pressure will be set at 5 cmH2O during controlled mechanical ventilation.
PEEP will be set at 5 cmH2O
Active Comparator: Group high PEEP
Positive end-expiratory pressure will be set at 10 cmH2O during controlled mechanical ventilation.
PEEP will be set at 10 cmH2O

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
regional cerebral oxygen saturation (SrO2) period 1
Time Frame: Pre-induction
The measurement of regional cerebral oxygen saturation before anesthesia induction
Pre-induction
regional cerebral oxygen saturation (SrO2) period 2
Time Frame: Up to 5 minutes after anethesia induction
The measurement of regional cerebral oxygen saturation after anesthesia induction
Up to 5 minutes after anethesia induction
regional cerebral oxygen saturation (SrO2) period 3
Time Frame: From skull-pinning to final head position
The measurement of regional cerebral oxygen saturation during skull pinning
From skull-pinning to final head position
regional cerebral oxygen saturation (SrO2) period 4
Time Frame: Just before dura opening
The measurement of regional cerebral oxygen saturation before dura opening
Just before dura opening
regional cerebral oxygen saturation (SrO2) period 5
Time Frame: Up to 5 minutes of dura opening
The measurement of regional cerebral oxygen saturation after dura opening
Up to 5 minutes of dura opening
regional cerebral oxygen saturation (SrO2) period 6
Time Frame: During surgical resection
The measurement of regional cerebral oxygen saturation during surgical resection of the mass
During surgical resection
regional cerebral oxygen saturation (SrO2) period 7
Time Frame: Up to 5 minutes of dura closure
The measurement of regional cerebral oxygen saturation after dura closure
Up to 5 minutes of dura closure
regional cerebral oxygen saturation (SrO2) period 8
Time Frame: Within 5 minutes after the surgery
The measurement of regional cerebral oxygen saturation at the end of surgery
Within 5 minutes after the surgery
regional cerebral oxygen saturation (SrO2) period 9
Time Frame: Within 5 minutes after end of anesthesia
The measurement of regional cerebral oxygen saturation at the end of anesthesia
Within 5 minutes after end of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Halide H Şahinkaya, MD, University of Health Sciences İzmir Bozyaka Education and Research Hospital
  • Study Chair: Çağlar Ayar, MD, University of Health Sciences İzmir Bozyaka Education and Research Hospital
  • Study Chair: Alper Tabanlı, MD, University of Health Sciences İzmir Bozyaka Education and Research Hospital
  • Study Chair: Zeki T Tekgül, MD, University of Health Sciences İzmir Bozyaka Education and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2023

Primary Completion (Estimated)

October 15, 2023

Study Completion (Estimated)

November 15, 2023

Study Registration Dates

First Submitted

June 30, 2023

First Submitted That Met QC Criteria

July 18, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 18, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Regional Cerebral Oxygen Saturation

Clinical Trials on 5 cmH2O Positive end-expiratory pressure (PEEP)

3
Subscribe